CDK19 抗体
Our Local Distributor
北京 101111
Quick Overview for CDK19 抗体 (ABIN7113163)
抗原
See all CDK19 抗体适用
宿主
克隆类型
标记
应用范围
-
-
原理
- CDK19 antibody
-
纯化方法
- Immunogen affinity purified
-
纯度
- ≥95 % as determined by SDS-PAGE
-
免疫原
- cell division cycle 2-like 6(CDK8-like)
-
亚型
- IgG
-
-
anti-Cyclin-Dependent Kinase 19 (CDK19) (AA 367-467) antibody
CDK19 适用: 人 WB, ELISA, IF 宿主: 小鼠 Monoclonal 8B6 unconjugated
anti-Cyclin-Dependent Kinase 19 (CDK19) antibodyCDK19 适用: 人, 小鼠 WB, ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Cyclin-Dependent Kinase 19 (CDK19) (AA 1-502) antibodyCDK19 适用: 人 WB, IP 宿主: 兔 Polyclonal unconjugated
anti-Cyclin-Dependent Kinase 19 (CDK19) (C-Term) antibodyVerified CDK19 适用: 人 ELISA, FACS, IF 宿主: 山羊 Polyclonal unconjugated
anti-Cyclin-Dependent Kinase 19 (CDK19) (AA 1-114) antibodyCDK19 适用: 人 ELISA, IHC (p) 宿主: 小鼠 Monoclonal 3D7 unconjugated
anti-Cyclin-Dependent Kinase 19 (CDK19) (AA 253-285) antibodyCDK19 适用: 人, 小鼠 WB, IHC (p), FACS 宿主: 兔 Polyclonal RB16914 unconjugated
anti-Cyclin-Dependent Kinase 19 (CDK19) (C-Term) antibodyCDK19 适用: 人, 小鼠 WB, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Cyclin-Dependent Kinase 19 (CDK19) (AA 1-502) antibodyCDK19 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-Cyclin-Dependent Kinase 19 (CDK19) (AA 1-114) antibodyCDK19 适用: 人 ELISA, IF 宿主: 小鼠 Monoclonal 2C6 unconjugated
-
-
应用备注
- WB: 1:500-1:2000
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Avoid repeated freeze / thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- -20°C for 12 months
-
有效期
- 12 months
-
-
- CDK19 (Cyclin-Dependent Kinase 19 (CDK19))
-
别名
- CDK19
-
背景
- Cyclin-dependent kinase 19|CDC2-related protein kinase 6|Cell division cycle 2-like protein kinase 6|Cell division protein kinase 19|Cyclin-dependent kinase 11|Death-preventing kinase|CDK19|CDC2L6|CDK11|KIAA1028
-
分子量
- 60-64 kDa
-
UniProt
- Q9BWU1
-
途径
- Regulation of Lipid Metabolism by PPARalpha
抗原
-
